Clinical Colorectal Cancer

Papers
(The H4-Index of Clinical Colorectal Cancer is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Radiomics for the Prediction of Treatment Outcome and Survival in Patients With Colorectal Cancer: A Systematic Review64
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer55
Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program52
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population44
Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study44
The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?36
Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer33
HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer32
Current Microsatellite Instability Testing in Management of Colorectal Cancer29
Clinical Updates for Colon Cancer Care in 202227
Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer24
The Landscape of PIK3CA Mutations in Colorectal Cancer23
COVID-19 and the Global Impact on Colorectal Practice and Surgery22
Rapamycin Extends Life Span in Apc Colon Cancer FAP Model22
Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer22
MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response22
Genetic Characteristics of Colorectal Neuroendocrine Carcinoma: More Similar to Colorectal Adenocarcinoma21
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis20
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial20
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Colle20
0.032928943634033